These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26363637)

  • 1. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
    Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recent antibiotics on nasopharyngeal carriage and lower airway infection in Indigenous Australian children with non-cystic fibrosis bronchiectasis.
    Hare KM; Leach AJ; Morris PS; Smith-Vaughan H; Torzillo P; Bauert P; Cheng AC; McDonald MI; Brown N; Chang AB; Grimwood K
    Int J Antimicrob Agents; 2012 Oct; 40(4):365-9. PubMed ID: 22819151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis.
    Hare KM; Singleton RJ; Grimwood K; Valery PC; Cheng AC; Morris PS; Leach AJ; Smith-Vaughan HC; Chatfield M; Redding G; Reasonover AL; McCallum GB; Chikoyak L; McDonald MI; Brown N; Torzillo PJ; Chang AB
    PLoS One; 2013; 8(8):e70478. PubMed ID: 23940582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-sectional survey at delivery.
    Unger HW; Aho C; Ome-Kaius M; Wangnapi RA; Umbers AJ; Jack W; Lafana A; Michael A; Hanieh S; Siba P; Mueller I; Greenhill AR; Rogerson SJ
    J Clin Microbiol; 2015 Apr; 53(4):1317-23. PubMed ID: 25673788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
    Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
    BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Impact of Oral Azithromycin Taken by Gambian Women During Labor on Prevalence and Antibiotic Susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in Their Infants: Follow-up of a Randomized Clinical Trial.
    Bojang A; Camara B; Jagne Cox I; Oluwalana C; Lette K; Usuf E; Bottomley C; Howden BP; D'Alessandro U; Roca A
    Clin Infect Dis; 2018 Sep; 67(8):1191-1197. PubMed ID: 29608659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility and impact of macrolide antibiotics on Moraxella catarrhalis in the upper and lower airways of children with chronic endobronchial suppuration.
    Hare KM; Seib KL; Chang AB; Harris TM; Spargo JC; Smith-Vaughan HC
    J Med Microbiol; 2019 Aug; 68(8):1140-1147. PubMed ID: 31274402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier children.
    Swedan SF; Hayajneh WA; Bshara GN
    Indian J Med Microbiol; 2016; 34(2):159-65. PubMed ID: 27080766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins.
    Jourdain S; Smeesters PR; Denis O; Dramaix M; Sputael V; Malaviolle X; Van Melderen L; Vergison A
    Clin Microbiol Infect; 2011 Jun; 17(6):907-14. PubMed ID: 20977542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
    Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
    Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study.
    Berg HF; Tjhie JH; Scheffer GJ; Peeters MF; van Keulen PH; Kluytmans JA; Stobberingh EE
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4183-8. PubMed ID: 15504839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.